GlaxoSmithKline PLC (GSK.L)

GSK.L on London Stock Exchange

1,347.50GBp
3 Jul 2015
Change (% chg)

-7.50p (-0.55%)
Prev Close
1,355.00p
Open
1,355.00p
Day's High
1,362.00p
Day's Low
1,342.50p
Volume
3,385,155
Avg. Vol
9,748,410
52-wk High
1,645.00p
52-wk Low
1,296.50p

GSK.L

Chart for GSK.L

About

GlaxoSmithKline plc. (GSK) is a healthcare company that researches and develops pharmaceuticals, vaccines and consumer healthcare products. The Company operates in two segments: Pharmaceuticals and Vaccines, and Consumer Healthcare. The Pharmaceuticals segment develops and makes medicines to treat a range of acute and chronic... (more)

Overall

Beta: 0.60
Market Cap(Mil.): £65,574.60
Shares Outstanding(Mil.): 4,866.39
Dividend: 19.00
Yield (%): 5.94

Financials

  GSK.L Industry Sector
P/E (TTM): 6.39 35.83 39.81
EPS (TTM): 2.11 -- --
ROI: 31.01 17.03 16.23
ROE: 144.87 17.93 17.36
Search Stocks

Manufacturing deal wins China cheap supply of GSK's new HIV drug

LONDON - China will receive cut-price supplies of GlaxoSmithKline's new HIV drug Tivicay, following a deal for Shanghai-based Desano Pharmaceuticals to become an additional manufacturer of the medicine's active ingredient.

02 Jul 2015

Manufacturing deal wins China cheap supply of GSK's new HIV drug

LONDON, July 2 - China will receive cut-price supplies of GlaxoSmithKline's new HIV drug Tivicay, following a deal for Shanghai-based Desano Pharmaceuticals to become an additional manufacturer of the medicine's active ingredient.

02 Jul 2015

BRIEF-Valneva takes direct control over marketing & distribution of Ixiaro

* Takes direct control over marketing & distribution of Ixiaro

22 Jun 2015

GSK sells two vaccines to Pfizer to ease competition concerns

LONDON - GlaxoSmithKline has agreed to sell two meningitis vaccines to Pfizer to satisfy antitrust concerns after its recent acquisition of vaccines business of Novartis.

22 Jun 2015

GSK sells two vaccines to Pfizer to ease competition concerns

LONDON, June 22 - GlaxoSmithKline has agreed to sell two meningitis vaccines to Pfizer to satisfy antitrust concerns after its recent acquisition of vaccines business of Novartis.

22 Jun 2015

UK investigator says Chinese officials mistreated him to get GSK confession

LONDON/BEIJING - A British corporate investigator freed from a Chinese jail last week has accused officials there of deliberately withholding medical treatment to try to force him to confess to a role in a scandal involving drugmaker GlaxoSmithKline Plc (GSK).

18 Jun 2015

UK investigator says Chinese officials mistreated him to get GSK confession

LONDON/BEIJING, June 18 - A British corporate investigator freed from a Chinese jail last week has accused officials there of deliberately withholding medical treatment to try to force him to confess to a role in a scandal involving drugmaker GlaxoSmithKline Plc (GSK).

18 Jun 2015

China deports British, American investigators linked to GSK scandal

SHANGHAI - A British corporate sleuth and his American wife and business partner, both linked to a bribery scandal in China involving drugmaker GlaxoSmithKline PLC, were deported on Wednesday after their jail terms were reduced this month.

17 Jun 2015

REFILE-China deports British, American investigators linked to GSK scandal

SHANGHAI, June 17 - A British corporate sleuth and his American wife and business partner, both linked to a bribery scandal in China involving drugmaker GlaxoSmithKline PLC , were deported on Wednesday after their jail terms were reduced this month.

17 Jun 2015

GSK invests $95 million in effort to demystify cell 'operating system'

LONDON - British drugmaker GlaxoSmithKline is investing $95 million to create a new U.S. research institute led by a top genomics professor to investigate how a cell's operating system works.

16 Jun 2015

Earnings vs. Estimates

Search Stocks